Evaluation of the Efficacy and Safety of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease
Clinical trial NCT04036292 · COMPLETED
Trial details
- NCT number
- NCT04036292
- Sponsor
- Oyster Point Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-23
- Primary completion
- 2020-04-10
- Enrollment
- 758
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.